/Investor DB

Avant Bio — Full Portfolio

10 tracked investments · listed companies and verified rows first

ALPENGLOW BIOSCIENCES, INC.lightspeedmicro.comin𝕏Dec 2025SEC filingmedium confidence

Alpenglow Biosciences offers a 3D spatial biology platform (Aurora 3D) that uses open-top light-sheet microscopy and AI analysis to turn intact tissue into quantitative volumetric data.

AI & Machine LearningBiotechMedical DevicesSeattle, US

Board seatDaniella Kranjac· per SEC Form D · $3M raise · filed Dec 2025

RoosterBioroosterbio.comJul 2024SEC filingmedium confidence

RoosterBio supplies human mesenchymal stem/stromal cells (hMSCs), exosome systems, and cGMP media with built-in processes and protocols for companies and researchers developing cell therapy, gene therapy, and tissue engineering products.

Advanced ManufacturingBiotechMedical DevicesFrederick, US

Jon Rowley(Director)inTimothy Kelly(Executive Officer, Director)Margot Connor(Executive Officer, Director)Uplaksh Kumar(Chief Operating Officer)

BoardMartin Westberg(Director)Rob Carlson(Director)

Board seatDaniella Kranjac· per SEC Form D · $12M raise · filed Jul 2024

Co-investorsDynamk CapitalMaryland TEDCOTEDCOVanedge CapitalVanedge Capital Limited Partnership

Vernal Biosciencesvernal.bioin𝕏Jun 2023SEC filingmedium confidence

Vernal Biosciences is an mRNA contract development and manufacturing organization (CDMO) that produces high-quality mRNA for research and therapeutic development.

Advanced ManufacturingBiotechDeep TechMedical DevicesColchester, US

Christian Cobaugh(Chief Scientific Officer and Founder)in

BoardErrik Anderson(Director)

Board seatDaniella Kranjac· per SEC Form D · $41M raise · filed Jun 2023

Co-investorsDynamk CapitalAmpersand

Viricaviricabiotech.comin𝕏May 2024SEC filingmedium confidence

Virica is a biotech company that develops small-molecule "Viral Sensitizers" which temporarily reduce host cell defenses during viral vector production to increase yield, quality, and scalability.

Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesOttawa, CA

Jean-Simon Diallo(Founder)inKen Newport(Executive Officer)inElla Korets-Smith(Executive Officer)in

Board seatDaniella Kranjac· per SEC Form D · filed May 2024

Co-investorsDynamk Capital

Abbelightabbelight.cominJan 2026

Abbelight provides microscopy equipment, reagents, and services to researchers and biotech labs for studying biology at the molecular level.

BiotechDeep TechHardwareMedical Devices

Jean-Baptiste Marie(CEO and Co-founder)inNicolas Bourg(CTO and Co-founder)in

BoardSandrine Lévèque-Fort(Scientific Advisor)Emmanuel Fort(Scientific Advisor)

Co-investorsGENERAL INCEPTIONDynamk Capital

Intrepid Labsintrepidlabs.techin𝕏Jun 2025

Intrepid Labs applies active machine learning, robotics, and pharmaceutical science to accelerate the design and development of drug products and delivery formulations.

AI & Machine LearningBiotechRoboticsToronto, CA

Alán Aspuru-Guzik(Co-founder)inChristine Allen(Co-founder & CEO)inPauric Bannigan(Co-founder & Chief Scientific Officer)inRiley Hickman(Co-founder & Director of Research and Development)in

Co-investorsPropagator VenturesRadical VenturesWing

Nomic Bionomic.bioin𝕏

Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies.

BiotechDeep TechHealthtechMedical DevicesMontreal, CA

Milad Dagher(Founder)inJeff Munzar(Founder)inElisha Krauss(Operations Manager)Ani Muradyan(Recruiter)

Co-investorsAmplitude Venture CapitalFirst Star VenturesFront Row VenturesRaptor GroupY Combinator2048 Ventures+9 more

PathPresenterpathpresenter.comin𝕏

PathPresenter is a digital pathology platform used for viewing, sharing, and managing pathology images in clinical, research, and educational settings.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Raj Singh(Founder)Rajendra Singh(Co-founder)inCory Batenchuk(Senior Vice President, Operations & Co-founder)inKV Acharya(System Architect & Co-founder)inPatrick Myles(Chief Executive Officer)in

Co-investorsModi VenturesWing

PL BioSciencepl-bioscience.comin𝕏Aug 2024

PL BioScience develops human platelet-based cell culture media that promote cell growth, used in biotechnology research and cell culture applications.

BiotechNew Materials

Dr. Hatim Hemeda(Founder & CEO)

Co-investorsTechVision FondsBetter Ventures Central LlcBrightlands Venture PartnersSeed Fonds Aachen

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Primaa

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.